title: Epinephrine-induced myocardial infarction in severe anaphylaxis: is β-blocker a bad actor or bystander?
authors.affiliation: Department of Emergency & Critical Care Medicine, Sri Gokulam Hospitals & Research Institute, Salem, Tamil Nadu, India. Electronic address: maniansenthil@yahoo.co.in.
authors.forename: Subramanian
authors.initials: S
authors.lastname: Senthilkumaran
authors.forename: Suresh S
authors.initials: SS
authors.lastname: David
authors.forename: Narendra Nath
authors.initials: NN
authors.lastname: Jena
authors.forename: Ponniah
authors.initials: P
authors.lastname: Thirumalaikolundusubramanian
mesh_terms: D000707:Anaphylaxis / Q000188:drug therapy*; D018926:Anti-Allergic Agents / Q000009:adverse effects*; D003329:Coronary Vasospasm / Q000139:chemically induced*; D004837:Epinephrine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*
chemical_list: D018926:Anti-Allergic Agents; D004837:Epinephrine